Cargando…

A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial

BACKGROUND/OBJECTIVES: Lipopolysaccharide-binding protein (LBP), a biomarker of gut barrier permeability to lipopolysaccharides, is higher in adults with obesity and type 2 diabetes. Behavioral weight loss and metformin have distinct effects on the gut microbiome, but their impact on gut permeabilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilves, Curtis, Yeh, Hsin-Chieh, Maruthur, Nisa, Juraschek, Stephen P., Miller, Edgar, Appel, Lawrence J., Mueller, Noel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881332/
https://www.ncbi.nlm.nih.gov/pubmed/34987204
http://dx.doi.org/10.1038/s41366-021-01039-2
_version_ 1784659450152353792
author Tilves, Curtis
Yeh, Hsin-Chieh
Maruthur, Nisa
Juraschek, Stephen P.
Miller, Edgar
Appel, Lawrence J.
Mueller, Noel T.
author_facet Tilves, Curtis
Yeh, Hsin-Chieh
Maruthur, Nisa
Juraschek, Stephen P.
Miller, Edgar
Appel, Lawrence J.
Mueller, Noel T.
author_sort Tilves, Curtis
collection PubMed
description BACKGROUND/OBJECTIVES: Lipopolysaccharide-binding protein (LBP), a biomarker of gut barrier permeability to lipopolysaccharides, is higher in adults with obesity and type 2 diabetes. Behavioral weight loss and metformin have distinct effects on the gut microbiome, but their impact on gut permeability to lipopolysaccharides is unknown. This study’s objective was to determine the effects of a behavioral weight loss intervention or metformin treatment on plasma LBP. SUBJECTS/METHODS: SPIRIT was a randomized trial of adults with overweight or obesity. Participants were randomized to one of three arms: metformin treatment, coach-directed behavioral weight loss on a DASH diet, or self-directed care (control). Of 121 participants, a random subset (n=88) was selected to have LBP measured at baseline, 6-months, and 12-months post intervention. Intervention effects on LBP over time were assessed using generalized estimating equations (GEE). We also examined whether the intervention effects were modified by change in diet and weight. RESULTS: Arms were balanced by sex (83% female), race (51% white), and age (mean 60 years), with no differences in baseline LBP (median 4.23 μg/mL). At 1 year, mean weight change was −3.00% in the metformin arm, −3.02% in the coach-directed behavioral weight-loss arm, and +0.33% in the self-directed (control) arm. The corresponding change in LBP was +1.03, −0.98, +1.03 μg/mL. The behavioral weight-loss reduced LBP compared to self-directed care (β=−0.17, 95% CI: −0.33 to −0.01); no other between-arm comparisons were significant. Participants who reduced dietary fat showed the greatest reductions in 6-month LBP (β=−2.84, 95% CI: −5.17 to −0.50). CONCLUSIONS: Despite similar weight loss in the behavioral weight loss and metformin arms, only the behavioral weight loss intervention reduced LBP compared to control. Lifestyle weight loss interventions that promote a DASH diet may be effective at reducing gut barrier permeability to lipopolysaccharides.
format Online
Article
Text
id pubmed-8881332
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-88813322022-07-06 A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial Tilves, Curtis Yeh, Hsin-Chieh Maruthur, Nisa Juraschek, Stephen P. Miller, Edgar Appel, Lawrence J. Mueller, Noel T. Int J Obes (Lond) Article BACKGROUND/OBJECTIVES: Lipopolysaccharide-binding protein (LBP), a biomarker of gut barrier permeability to lipopolysaccharides, is higher in adults with obesity and type 2 diabetes. Behavioral weight loss and metformin have distinct effects on the gut microbiome, but their impact on gut permeability to lipopolysaccharides is unknown. This study’s objective was to determine the effects of a behavioral weight loss intervention or metformin treatment on plasma LBP. SUBJECTS/METHODS: SPIRIT was a randomized trial of adults with overweight or obesity. Participants were randomized to one of three arms: metformin treatment, coach-directed behavioral weight loss on a DASH diet, or self-directed care (control). Of 121 participants, a random subset (n=88) was selected to have LBP measured at baseline, 6-months, and 12-months post intervention. Intervention effects on LBP over time were assessed using generalized estimating equations (GEE). We also examined whether the intervention effects were modified by change in diet and weight. RESULTS: Arms were balanced by sex (83% female), race (51% white), and age (mean 60 years), with no differences in baseline LBP (median 4.23 μg/mL). At 1 year, mean weight change was −3.00% in the metformin arm, −3.02% in the coach-directed behavioral weight-loss arm, and +0.33% in the self-directed (control) arm. The corresponding change in LBP was +1.03, −0.98, +1.03 μg/mL. The behavioral weight-loss reduced LBP compared to self-directed care (β=−0.17, 95% CI: −0.33 to −0.01); no other between-arm comparisons were significant. Participants who reduced dietary fat showed the greatest reductions in 6-month LBP (β=−2.84, 95% CI: −5.17 to −0.50). CONCLUSIONS: Despite similar weight loss in the behavioral weight loss and metformin arms, only the behavioral weight loss intervention reduced LBP compared to control. Lifestyle weight loss interventions that promote a DASH diet may be effective at reducing gut barrier permeability to lipopolysaccharides. 2022-03 2022-01-06 /pmc/articles/PMC8881332/ /pubmed/34987204 http://dx.doi.org/10.1038/s41366-021-01039-2 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms
spellingShingle Article
Tilves, Curtis
Yeh, Hsin-Chieh
Maruthur, Nisa
Juraschek, Stephen P.
Miller, Edgar
Appel, Lawrence J.
Mueller, Noel T.
A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial
title A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial
title_full A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial
title_fullStr A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial
title_full_unstemmed A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial
title_short A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial
title_sort behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: results from the spirit randomized trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881332/
https://www.ncbi.nlm.nih.gov/pubmed/34987204
http://dx.doi.org/10.1038/s41366-021-01039-2
work_keys_str_mv AT tilvescurtis abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT yehhsinchieh abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT maruthurnisa abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT juraschekstephenp abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT milleredgar abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT appellawrencej abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT muellernoelt abehavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT tilvescurtis behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT yehhsinchieh behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT maruthurnisa behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT juraschekstephenp behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT milleredgar behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT appellawrencej behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial
AT muellernoelt behavioralweightlossinterventionbutnotmetformindecreasesamarkerofgutbarrierpermeabilityresultsfromthespiritrandomizedtrial